Primary |
Asthma |
41.1% |
Chronic Obstructive Pulmonary Disease |
23.1% |
Drug Use For Unknown Indication |
13.6% |
Product Used For Unknown Indication |
13.4% |
Emphysema |
2.0% |
Bronchitis |
1.4% |
Cough |
0.9% |
Dyspnoea |
0.9% |
Hypertension |
0.6% |
Wheezing |
0.5% |
Pneumonia |
0.4% |
Multiple Allergies |
0.4% |
Lung Disorder |
0.3% |
Prophylaxis |
0.2% |
Respiratory Disorder |
0.2% |
Bronchiectasis |
0.2% |
Pain |
0.2% |
Osteoporosis |
0.2% |
Depression |
0.2% |
Bronchitis Chronic |
0.1% |
|
Product Quality Issue |
20.3% |
Pharmaceutical Product Complaint |
11.3% |
Drug Ineffective |
8.3% |
Dysphonia |
8.0% |
Dyspnoea |
7.4% |
Pneumonia |
6.4% |
Death |
5.1% |
Wheezing |
4.6% |
Asthma |
3.9% |
Candidiasis |
3.1% |
Throat Irritation |
3.1% |
Cough |
3.0% |
Tremor |
2.7% |
Weight Increased |
2.6% |
Vision Blurred |
2.0% |
Adverse Event |
1.9% |
Malaise |
1.7% |
Respiratory Disorder |
1.6% |
Oropharyngeal Pain |
1.5% |
Overdose |
1.5% |
|
Secondary |
Asthma |
28.4% |
Chronic Obstructive Pulmonary Disease |
22.3% |
Drug Use For Unknown Indication |
13.3% |
Product Used For Unknown Indication |
9.2% |
Emphysema |
4.8% |
Hypertension |
3.5% |
Bronchitis |
2.9% |
Depression |
2.5% |
Smoking Cessation Therapy |
2.1% |
Hypersensitivity |
1.6% |
Dyspnoea |
1.4% |
Blood Cholesterol Increased |
1.4% |
Prophylaxis |
1.2% |
Pain |
1.0% |
Bronchitis Chronic |
0.9% |
Gastrooesophageal Reflux Disease |
0.9% |
Anxiety |
0.8% |
Diabetes Mellitus |
0.8% |
Cough |
0.6% |
Infection |
0.6% |
|
Drug Ineffective |
8.3% |
Pneumonia |
7.9% |
Product Quality Issue |
7.9% |
Weight Increased |
7.7% |
Tremor |
7.4% |
Dysphonia |
7.2% |
Dyspnoea |
7.0% |
Wheezing |
5.9% |
Vision Blurred |
4.5% |
Death |
4.3% |
Vomiting |
4.3% |
Asthma |
3.8% |
Therapeutic Response Decreased |
3.4% |
Vocal Cord Disorder |
3.4% |
Pharmaceutical Product Complaint |
3.2% |
Dry Mouth |
2.9% |
Nausea |
2.9% |
Pulmonary Embolism |
2.9% |
Rotator Cuff Syndrome |
2.7% |
Throat Irritation |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
20.0% |
Asthma |
16.1% |
Drug Use For Unknown Indication |
15.6% |
Chronic Obstructive Pulmonary Disease |
11.4% |
Hypertension |
5.5% |
Pain |
4.0% |
Depression |
3.2% |
Gastrooesophageal Reflux Disease |
2.5% |
Smoking Cessation Therapy |
2.5% |
Osteoporosis |
2.4% |
Hypersensitivity |
2.0% |
Emphysema |
2.0% |
Anxiety |
2.0% |
Blood Cholesterol Increased |
2.0% |
Diabetes Mellitus |
2.0% |
Rheumatoid Arthritis |
2.0% |
Dyspnoea |
1.7% |
Prophylaxis |
1.2% |
Non-small Cell Lung Cancer |
1.1% |
Back Pain |
1.0% |
|
Dyspnoea |
10.8% |
Vomiting |
9.9% |
Weight Decreased |
8.7% |
Drug Ineffective |
7.8% |
Pneumonia |
6.8% |
Weight Increased |
6.5% |
Nausea |
5.5% |
Wheezing |
5.4% |
Death |
4.5% |
Pain |
3.7% |
Urticaria |
3.7% |
Pulmonary Embolism |
3.5% |
Asthma |
3.4% |
Rash |
3.4% |
Vision Blurred |
3.4% |
Myocardial Infarction |
3.1% |
Tremor |
3.0% |
Headache |
2.4% |
Pruritus |
2.3% |
Somnolence |
2.3% |
|
Interacting |
Asthma |
17.6% |
Drug Use For Unknown Indication |
15.5% |
Dyspnoea |
15.5% |
Smoking Cessation Therapy |
9.9% |
Chronic Obstructive Pulmonary Disease |
7.0% |
Hiv Infection |
6.3% |
Gastric Disorder |
4.2% |
Pain |
4.2% |
Emphysema |
3.5% |
Nervous System Disorder |
2.1% |
Anxiety |
1.4% |
Arthralgia |
1.4% |
Arthritis |
1.4% |
Blood Cholesterol Increased |
1.4% |
Constipation |
1.4% |
Ex-smoker |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
Hypothyroidism |
1.4% |
Insomnia |
1.4% |
Osteoporosis |
1.4% |
|
Weight Increased |
17.9% |
Drug Interaction |
14.3% |
Cerebrovascular Accident |
10.7% |
Pain |
10.7% |
Dyspnoea |
7.1% |
Urinary Tract Infection |
7.1% |
Abasia |
3.6% |
Abdominal Discomfort |
3.6% |
Hyperglycaemia |
3.6% |
Nausea |
3.6% |
Pneumonia |
3.6% |
Respiratory Distress |
3.6% |
Swollen Tongue |
3.6% |
Ulcer |
3.6% |
Wheezing |
3.6% |
|